Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy
Comparison of Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy: A Randomized Controlled Trial
National Cancer Institute, Egypt
110 participants
Jan 24, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.
Eligibility
Inclusion Criteria4
- Adult females \> 18 years and ≤ 65 years old.
- American Society of Anesthesiologists (ASA) physical status П-III.
- Body mass index (BMI) 18-35 kg/m2.
- Scheduled for modified radical mastectomy.
Exclusion Criteria6
- Known allergy or hypersensitivity to local anesthetic agents.
- Active infection at the injection site (e.g., cellulitis, abscess).
- Coagulopathy or ongoing anticoagulant/antiplatelet therapy \[International Normalized Ratio (INR) \> 1.5 or platelet count \< 100,000/µL\].
- Severe respiratory, cardiac, hepatic, or renal disease.
- Morbid obesity.
- Severe cognitive impairment or uncooperative behavior that could interfere with block placement.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.
Patients will receive an ipsilateral ultrasound-guided erector spinae plane block with injection of 20 ml bupivacaine 0.25%.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07367568